Mealey's (December 18, 2020, 12:54 PM EST) -- KANSAS CITY, Kan. — The Kansas federal judge overseeing the EpiPen multidistrict litigation on Dec. 16 “reluctantly” agreed to postpone an April 13 class action trial due to the continuing COVID-19 pandemic (In Re: EpiPen [Epinephrine Injection, USP] Marketing, Sales Practices and Antitrust Litigation, MDL Docket No. 2785, No. 17-md-2785, D. Kan.)....